# Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists.

> PubMed lists PMID 41518129 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Review, with publication-date metadata of 2026-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41518129-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41518129-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41518129-glucagon-v1.json
- Content SHA-256: `09a47fa866c32aed92bd85a29f7ef27c94c4bcf27437863d054661813f3c4ae9`

## Claims and source pins

### Headline

Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists. ([`pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a`](#source-pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a))

### Summary

PubMed lists PMID 41518129 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Review, with publication-date metadata of 2026-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a`](#source-pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a))

### Paragraph 1

PubMed lists PMID 41518129 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Review, with publication-date metadata of 2026-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a`](#source-pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a`](#source-pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a))

## Sources

<a id="source-pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a"></a>
- **Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists. · retained source version 1:2026-06-25:current:02c52228e57a7c394f35c1e8133427046e54d5c50ffcc62fdf2b762a4c05e0ff** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41518129/) (`pubmed-observation-pmid-41518129-2026-06-25-02c52228e57a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists." Version 1, published 2026-08-16. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41518129-glucagon-v1.json SHA-256: 09a47fa866c32aed92bd85a29f7ef27c94c4bcf27437863d054661813f3c4ae9.